Analysts' Actions: BSX CNK DELL LULU VZ
NEW YORK (TheStreet) -- CHANGE IN RATINGS
Boston Scientific (BSX) was upgraded at JMP Securities to outperform from market perform. $9 price target. Company is on the cusp of a multiyear growth period, JMP said.
Buenaventura Mining (BVN) was downgraded to hold at TheStreet Ratings.
Carbo Ceramics (CRR) was upgraded to buy at TheStreet Ratings.
Cinemark (CNK) was downgraded at JP Morgan from overweight to neutral. $30 price target. Valuation call, as the stock is up 53% year to date, JP Morgan said.
Deckers Outdoor (DECK) was upgraded at Sterne Agee from neutral to buy. $65 price target. Business can turn by the second half of 2013, Sterne Agee said.
Dell (DELL) was upgraded at Goldman Sachs from sell to buy. $13 price target. Solid cash position should help place a floor on the stock, Goldman said.
Edison International (EIX) was downgraded at Bernstein Research to market perform. Valuation call, based on a $50 price target. Company faces potential growth headwinds, Bernstein said.
Eaton Vance (EV) was upgraded at Goldman Sachs to neutral from sell. $29.50 price target. Better flow outlook, but valuation still stretched, Goldman said.
Finisar (FNSR) was upgraded at Needham from hold to buy. $18 price target. Service provider spending should increase over the coming quarters for the company's new products, Needham said.
International Game (IGT) was upgraded at Deutsche Bank from hold to buy. $19 price target. Worst operating trends are likely behind the company, Deutsche Bank.
Janus Capital Group (JNS) was downgraded at Goldman Sachs to sell from neutral. $7 price target. Tougher flow outlook not priced in, Goldman said.
Lululemon (LULU) was initiated with a buy rating at Canaccord Genuity. $91 price target. Company is evolving beyond its athletic roots, Canaccord said.
Occidental Petroleum (OXY) was downgraded at Deutsche Bank from buy to hold. $80 price target.
PartnerRe (PRE) was downgraded at UBS to neutral from buy. $84 price target. Valuation call, UBS said.
Bankrate (RATE) was downgraded at Canaccord Genuity to hold. $14 price target. Company faces tough comps, Canaccord said.